Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2017 April;69(2) > Minerva Urologica e Nefrologica 2017 April;69(2):119-32

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEW  


Minerva Urologica e Nefrologica 2017 April;69(2):119-32

DOI: 10.23736/S0393-2249.16.02743-0

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review

Simone ALBISINNI 1 , Fouad AOUN 1, Thierry ROUMEGUÈRE 1, Francesco PORPIGLIA 2, Andrea TUBARO 3, Cosimo DE NUNZIO 3

1 Urology Department, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium; 2 Department of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy; 3 Department of Urology, University “La Sapienza”, Sant’Andrea Hospital, Rome, Italy


FULL TEXT  


INTRODUCTION: Life expectancy is constantly increasing and as a consequence older men, frequently with multiple comorbidities, are seeking treatment for benign prostatic hyperplasia. Given their frail health, these men need extreme attention in their management, as efficacious and safe treatment strategies in the general population may not be adequate for them.
EVIDENCE ACQUISITION: The National Library of Medicine Database was searched for relevant articles published between 2006 and 2015. Each article’s title, abstract and text were reviewed for their appropriateness and their relevance. 57 articles were eligible for the review.
EVIDENCE SYNTHESIS: In the elderly and frail, α1-antagonists should be used with caution given the risk of orthostatic hypotension and consequent falls, cause of significant morbidity in the elderly. 5ARIs present a good safety profile. Anticholinergics must also be prescribed with caution, given the risk of aggravating symptoms of dementia due to a central blockage of cholinergic neuronal pathways. Prostatic urethral lift is a medical device with low morbidity and valid functional results, which appear to endure over time. Prostatic artery embolization is demonstrating good results with minimal complication rates. Laser prostate vaporization or enucleation is also safe in elderly men and in those receiving anticoagulation therapy, due to its excellent hemostatic effect on prostatic tissue.
CONCLUSIONS: Urologists should be familiar with the safety and efficacy profile of medical and surgical therapy in the elderly population, given the inevitable increase in older patients which we will observe in the near future.


KEY WORDS: Prostatic hyperplasia - Frail elderly - Prostate

top of page

Publication History

Issue published online: February 28, 2017
Article first published online: September 28, 2016

Cite this article as

Albisinni S, Aoun F, Roumeguère T, Porpiglia F, Tubaro A, De Nunzio C. New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review. Minerva Urol Nefrol 2017;69:119-32. DOI: 10.23736/S0393-2249.16.02743-0

Corresponding author e-mail

albisinni.simone@gmail.com